Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 10 days · Every feed →

All 7,309Congress 2,157Executive branch 468Insiders 4,684
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

Insiders · filed late · 4,684 trades

Trades
4,684
Buys 1,074 · Sells 3,610
People
1,192
Stocks
723
Disclosed value
$7.6B
range midpoints · Congress & executive
Filed late
4,684
  1. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$3.2Kdisclosed Jun 10 · filed 8 days after the trade · late
  2. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$35.4Kdisclosed Jun 10 · filed 78 days after the trade · late
  3. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  4. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jun 10 · filed 9 days after the trade · late
  5. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$924Kdisclosed Jun 10 · filed 78 days after the trade · late
  6. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$11Kdisclosed Jun 10 · filed 7 days after the trade · late
  7. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$908Kdisclosed Jun 10 · filed 84 days after the trade · late
  8. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$1.1Kdisclosed Jun 10 · filed 7 days after the trade · late
  9. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late